Papp L Roy & Associates Lucira Health, Inc. Transaction History

Papp L Roy & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$0.11 - $0.83 $3,982 - $30,050	36,205 Added 31.62%	150,699 $0
Q3 2022 Oct 21, 2022	SELL	$1.27 - $3.39 $12,700 - $33,900	-10,000 Reduced 8.03%	114,494 $121,000
Q2 2022 Aug 02, 2022	BUY	$1.44 - $3.94 $23,744 - $64,966	16,489 Added 15.27%	124,494 $232,000
Q1 2022 May 06, 2022	BUY	$2.86 - $8.83 $178,764 - $551,919	62,505 Added 137.37%	108,005 $386,000
Q4 2021 Feb 11, 2022	SELL	$4.94 - $8.94 $1,729 - $3,129	-350 Reduced 0.76%	45,500 $392,000
Q3 2021 Nov 09, 2021	BUY	$6.05 - $10.81 $277,392 - $495,638	45,850 New	45,850 $348,000
Q2 2021 Aug 09, 2021	SELL	$4.56 - $11.45 $206,795 - $519,257	-45,350 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$11.65 - $37.0 $528,327 - $1.68 Million	45,350 New	45,350 $549,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

Stay updated on Papp L Roy & Associates with notifications on news.